ADVANCED RENAL CELL CARCINOMA
Clinical trials for ADVANCED RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced kidney cancer: experimental drug trial launches
Disease control Recruiting nowThis study tests a new medicine, PF-08634404, for adults with advanced kidney cancer that has spread. The goal is to see if the drug, given alone or with other cancer treatments, can shrink tumors and is safe. Participants must not have had prior treatment for their advanced canc…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 15, 2026 12:00 UTC
-
Engineered immune cells take on three tough cancers
Disease control Recruiting nowThis study tests a new treatment using donated immune cells (NK cells) that are specially engineered to attack cancer cells. About 50 adults with advanced kidney cancer, mesothelioma, or bone cancer will receive these cells along with chemotherapy to weaken their immune system fi…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New hope for kidney cancer: drug combo trial targets patients who failed first therapy
Disease control Recruiting nowThis study tests a new drug (zanzalintinib) alone or with an immunotherapy (nivolumab) in 70 adults with advanced kidney cancer that worsened after standard initial treatment. The goal is to see if the combination shrinks tumors better than the drug alone. Participants will take …
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Karie Runcie • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New hope for advanced kidney cancer: drug combo trial launches
Disease control Recruiting nowThis study tests a combination of three drugs (SHR-8068, adebrelimab, and others) in 139 adults with advanced kidney cancer that cannot be removed by surgery or has spread. The goal is to see if the treatment can shrink tumors and control the disease. Participants must provide a …
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Electric field device shows promise in taming advanced cancers
Disease control Recruiting nowThis early-phase study tests a wearable device that creates low-intensity electric fields (tumor treating fields) combined with either cabozantinib or a chemo-immunotherapy pair (nab-paclitaxel and atezolizumab) in people with advanced solid tumors in the abdomen or chest. The go…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
Morning vs. afternoon: can timing boost cancer immunotherapy?
Symptom relief Recruiting nowThis study looks at whether getting immunotherapy in the morning or afternoon changes how well it fights advanced or metastatic solid tumors. Researchers believe the body's internal clock (circadian rhythm) might affect immune response. About 160 adults with certain cancers like …
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE4 • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated May 16, 2026 23:47 UTC
-
Cancer patients may soon get immunotherapy at home – no more long clinic trips!
Symptom relief Recruiting nowThis study looks at whether giving the cancer drug nivolumab as a shot at home is as good as getting it at the clinic. About 50 adults with various cancers will try both ways to see which they prefer and how it affects their quality of life. The goal is to reduce the time, cost, …
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 16, 2026 23:46 UTC
-
Cancer care at home: a game changer for patients?
Symptom relief Recruiting nowThis study compares giving cancer treatment at home versus in a clinic for people with advanced cancers. The goal is to see if home treatment reduces stress, financial burden, and improves the overall experience. About 220 participants will be randomly assigned to receive their t…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC